Study of Oral Fampridine-SR in Multiple Sclerosis

NCT00127530 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Fampridine-SR
DRUG: Placebo

Sponsor

Acorda Therapeutics